(Reuters) – Futures tracking the S&P 500 and Dow indexes pared early declines to trade marginally higher, as hopes of a coronavirus vaccine offset concerns about the economic damage from a surge in domestic COVID-19 infections.
German biotech firm BioNTech (BNTX.O) and U.S. drugmaker Pfizer (PFE.N) reported additional data from their experimental coronavirus vaccine that showed the vaccine was safe and induced an immune response in patients.
At 9:01 a.m. ET, Dow e-minis 1YMcv1 were up 15 points, or 0.06%, and S&P 500 e-minis EScv1 were up 1.25 points, or 0.04%. Nasdaq 100 e-minis NQcv1, which were up before the report, hit session highs.
Source: Read Full Article